Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models.
Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models. J Clin Invest. 2021 02 01; 131(3).